The total cost of care and the use of pharmaceuticals in the management of rheumatoid arthritis: The medi-cal program
- 31 December 1988
- journal article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 41 (3) , 215-223
- https://doi.org/10.1016/0895-4356(88)90124-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Cost Effects of Restricting Cost-effective TherapyMedical Care, 1985
- National Medical Care SpendingHealth Affairs, 1984
- Practices, strategies, and motivations in treatment of rheumatoid arthritisThe American Journal of Medicine, 1983
- Penicillamine: An anti-rheumatoid drugThe American Journal of Medicine, 1983
- Antimalarial drugs for rheumatoid arthritisThe American Journal of Medicine, 1983
- Pathogenesis of the joint disease of rheumatoid arthritisThe American Journal of Medicine, 1983
- Current trends in the treatment of rheumatoid arthritisThe American Journal of Medicine, 1983
- Auranofin in the treatment of juvenile rheumatoid arthritisThe Journal of Pediatrics, 1983
- Newborn Risk Factors and Costs of Neonatal Intensive CarePediatrics, 1981
- Painful jointsPostgraduate Medicine, 1978